Matthew Buten - Net Worth and Insider Trading
Matthew Buten Net Worth
The estimated net worth of Matthew Buten is at least $10 Million dollars as of 2024-11-05. Matthew Buten is the CFO of Biohaven Ltd and owns about 189,380 shares of Biohaven Ltd (BHVN) stock worth over $10 Million. Details can be seen in Matthew Buten's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Buten has not made any transactions after 2023-10-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Buten
Matthew Buten Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Buten owns 2 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , and Biohaven Ltd (BHVN) .
Click here to see the complete history of Matthew Buten’s form 4 insider trades.
Insider Ownership Summary of Matthew Buten
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2021-12-08 | Officer |
| BHVN | Biohaven Ltd | 2023-10-05 | Chief Financial Officer |
Matthew Buten Latest Holdings Summary
Matthew Buten currently owns a total of 1 stock. Matthew Buten owns 189,380 shares of Biohaven Ltd (BHVN) as of October 5, 2023, with a value of $10 Million.
Latest Holdings of Matthew Buten
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BHVN | Biohaven Ltd | 2023-10-05 | 189,380 | 50.75 | 9,611,035 |
Holding Weightings of Matthew Buten
Matthew Buten Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Buten has made a total of 2 transactions in Biohaven Ltd (BHVN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Biohaven Ltd is the acquisition of 22,727 shares on October 5, 2023, which cost Matthew Buten around $499,994.
Insider Trading History of Matthew Buten
- 1
Matthew Buten Trading Performance
GuruFocus tracks the stock performance after each of Matthew Buten's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Buten is 54.59%. GuruFocus also compares Matthew Buten's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Buten within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew Buten's insider trading performs compared to the benchmark.
Performance of Matthew Buten
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.81 | | | | | |
| Relative Return to S&P 500(%) | 15.47 | | | | | |
Matthew Buten Ownership Network
Ownership Network List of Matthew Buten
Ownership Network Relation of Matthew Buten
Matthew Buten Owned Company Details
What does Biohaven Pharmaceutical Holding Co Ltd do?
Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?
Matthew Buten is the Officer of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biohaven Pharmaceutical Holding Co Ltd Insider Transactions
Matthew Buten Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Buten. You might contact Matthew Buten via mailing address: 215 Church Street, New Haven Ct 06510.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
